Puma Biotechnology market cap PBYI

Share price times shares outstanding: what the whole company sells for, since 2012.

Puma Biotechnology is worth $568.9M at the close on Oct 23, 2026, at $11.02 a share.

That is up 116% over the last year and up 174% over five years.

Its highest close in our data was $8.2B in Sep 2014.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$568.9M	$290M	$568.9M	+83%
2025	$310.4M	$136.5M	$310.4M	+105%
2024	$151.2M	$110.4M	$338.2M	−27%
2023	$206M	$103.1M	$220M	+7%
2022	$193.1M	$82.3M	$223.6M	+55%
2021	$124.3M	$116.5M	$487.5M	−70%
2020	$408M	$275.5M	$529.9M	+21%
2019	$337.4M	$252.8M	$1.5B	−58%
2018	$804.3M	$763.2M	$3.7B	−78%
2017	$3.7B	$1.1B	$4.9B	+228%
2016	$1.1B	$763.1M	$2.2B	−56%
2015	$2.5B	$2.2B	$7.6B	−56%
2014	$5.8B	$1.7B	$8.2B	+93%
2013	$3B	$554.7M	$3B	+453%
2012	$538.6M	$225.4M	$590.5M	n/a

Companies in Drug Manufacturers - General nearest Puma Biotechnology's size, closest first, today.

Company	Market cap
PBYIPuma Biotechnology	$568.9M
IRWDIronwood Pharmaceuticals	$571.7M
ZVRAZevra Therapeutics	$582.6M
CRMDCorMedix	$611.9M
ARVNArvinas	$477.3M
COLLCollegium Pharmaceutical	$747.5M
ABUSArbutus Biopharma	$831M
AMPHAmphastar Pharmaceuticals	$1.1B
OMEROmeros	$1.2B
PCRXPacira BioSciences	$1.5B
ANABAnaptysbio	$1.5B
Peer median	$789.2M